These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation. Zafrir B J Cardiopulm Rehabil Prev; 2013; 33(5):263-73. PubMed ID: 23962982 [TBL] [Abstract][Full Text] [Related]
11. Complications leading to sudden cardiac death in pulmonary arterial hypertension. Demerouti EA; Manginas AN; Athanassopoulos GD; Karatasakis GT Respir Care; 2013 Jul; 58(7):1246-54. PubMed ID: 23271814 [TBL] [Abstract][Full Text] [Related]
12. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension. Blumberg FC; Arzt M; Lange T; Schroll S; Pfeifer M; Wensel R Eur J Heart Fail; 2013 Jul; 15(7):771-5. PubMed ID: 23507788 [TBL] [Abstract][Full Text] [Related]
13. Effects of Exercise Training on Exercise Capacity in Pulmonary Arterial Hypertension: A Systematic Review of Clinical Trials. Babu AS; Padmakumar R; Maiya AG; Mohapatra AK; Kamath RL Heart Lung Circ; 2016 Apr; 25(4):333-41. PubMed ID: 26703447 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction. Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042 [TBL] [Abstract][Full Text] [Related]
15. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Weinstein AA; Chin LM; Keyser RE; Kennedy M; Nathan SD; Woolstenhulme JG; Connors G; Chan L Respir Med; 2013 May; 107(5):778-84. PubMed ID: 23478192 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary vascular response to exercise in symptomatic heart failure with reduced ejection fraction and pulmonary hypertension. Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Grieten L; Dens J; Verhaert D; Janssens S; Tang WH; Mullens W Eur J Heart Fail; 2015 Mar; 17(3):320-8. PubMed ID: 25639263 [TBL] [Abstract][Full Text] [Related]
17. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Orriols M; Gomez-Puerto MC; Ten Dijke P Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. So PP; Davies RA; Chandy G; Stewart D; Beanlands RS; Haddad H; Pugliese C; Mielniczuk LM Am J Cardiol; 2012 May; 109(10):1504-9. PubMed ID: 22385756 [TBL] [Abstract][Full Text] [Related]